ClinicalTrials.gov
ClinicalTrials.gov Menu

Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01333124
Recruitment Status : Recruiting
First Posted : April 11, 2011
Last Update Posted : September 14, 2017
Sponsor:
Information provided by (Responsible Party):
Sang-Jae Park, National Cancer Center, Korea

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2017
  Estimated Study Completion Date : December 2017